ISPOR - PCV39 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE FOR THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL HIP AND KNEE REPLACEMENT IN PORTUGAL

Full Text

PCV39 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE FOR THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL HIP AND KNEE REPLACEMENT IN PORTUGAL

Abstract

Authors

C Mateus S Wolowacz JA Pereira

Back to Volume 12, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now